This study is looking at whether offering the MyRisk Hereditary Cancer Test alongside standard obstetric carrier screening (OCS) is a good idea for women. The MyRisk test checks for genetic changes like BRCA1 that can increase your risk for certain cancers. Researchers believe that pregnancy and planning for pregnancy are good times to offer this cancer screening. They want to see how many women choose to have both screenings and if this approach could help prevent cancer earlier, especially for groups of people who often don't get these tests. You can join if you are a woman between 18 and 55 years old, are pregnant or planning to get pregnant, and are already getting obstetric care at a WCM-affiliated site. The study aims to measure how many participants complete both screenings by the end of recruitment, which is expected in about two years.

Study design

This study plans to enroll 550 women. It is an interventional study, meaning participants will receive a specific intervention (the MyRisk Hereditary Cancer Test).

What's involved

You will be contacted by a genetics clinician to discuss the option of adding hereditary cancer screening to your obstetric carrier screening.

Compensation

Not stated in the trial record.

Follow-up

The primary goal is measured at approximately within the end of recruitment, expected at 2 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.